510(k) device
AMICUS Separator System
Fresenius Kabi USA,Llc · Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN, Unclassified) · First FDA decision Dec 4, 2018, newest Dec 4, 2018Anemia, clotting and blood disorders
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "AMICUS"
MAUDE reports
38
Brand "AMICUS", since 2015
PubMed studies
354
Mentioning "AMICUS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AMICUS Separator System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K180615 · Decided Dec 4, 2018 · 271 days after receipt
Device type: Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AMICUS", any status and sponsor, newest update first.
Fenwal, Inc.Not on our public-company list
NCT02372877 · 83 participants · Start May 2015 · Primary completion Dec 7, 2017
Device: Amicus Red Cell Exchange in SCD patients · For: Sickle Cell Anemia
Sites: Phoenix, Arizona; Detroit, Michigan; St Louis, Missouri · 6 sites in all
Fenwal, Inc.Not on our public-company list
NCT01210716 · 37 participants · Start Sep 2010 · Primary completion May 2011
Device: Therapeutic plasma exchange · For: Autoimmune Diseases; Renal Disorders; Hematologic Disorders and 1 more
Sites: New Haven, Connecticut; Rochester, Minnesota; Charlottesville, Virginia · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AMICUS", and for the whole product code for context.
This brand
38 reports: 16 malfunction, 17 injury, 4 death
Whole product code LKN
1,471 reports: 891 malfunction, 496 injury, 79 death
Newest reports for this brand
3004548776-2026-00373 · Received Sep 3, 2026 · Event dated May 14, 2026
Device type: Separator, Automated, Blood Cell, Diagnostic (GKT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Fever; High Blood Pressure/ Hypertension; Tachycardia
3004548776-2025-00605 · Received Dec 10, 2025 · Event dated Nov 13, 2025
Device type: Separator, Automated, Blood Cell, Diagnostic (GKT)
Device problem as coded: Microbial Contamination of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3004548776-2025-00581 · Received Nov 6, 2025 · Event dated Sep 29, 2025
Device type: Separator, Automated, Blood Cell, Diagnostic (GKT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Transfusion Reaction
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis platformOpen, Classified
Z-1254-2023 · Started Feb 14, 2023 · Posted by FDA Mar 15, 2023
Reason given: Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.
Cause as FDA categorized it: Process control · Device type: Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN)
- Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platformOpen, Classified
Z-1255-2023 · Started Feb 14, 2023 · Posted by FDA Mar 15, 2023
Reason given: Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.
Cause as FDA categorized it: Process control · Device type: Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN)
Z-1344-2021 · Started Feb 25, 2021
Reason given: Some lots of Amicus MNC Apheresis and Amicus Exchange kits have leaking centrifuge packs during a procedure on the Amicus Separator using therapeutic protocols only. The defect is a blood leak at the boot, elbow, or in the channel on the separation chamber of the centrifuge pack.
Cause as FDA categorized it: Under Investigation by firm · Device type: Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN)
1 more recall records with a free account
Published research
The most relevant PubMed records for "AMICUS"[tiab]. The summary above synthesizes these.
- Amicus Brief.
Nussbaum MC · Perspect Biol Med · 2023
- Amicus Brief.
Korsgaard CM · Perspect Biol Med · 2023
- Cipaglucosidase Alfa: First Approval.
Blair HA · Drugs · 2023Review
- Being an end-of-life doula.
Murphy S · Br J Community Nurs · 2021
- Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.
Middleton EA, Rondina MT, Schwertz H, et al. · Am J Respir Cell Mol Biol · 2018Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Combating Scientific Disinformation on Gender-Affirming Care.
McNamara M, Abdul-Latif H, Boulware SD, et al. · Pediatrics · 2023
- NIKOLAI IVANOVICH PIROGOV - AMICUS HUMANI GENERIS.
Bieliaieva OM, Skrypnikova TP, Lysanets YV, et al. · Wiad Lek · 2021Historical Article
- The Important Role of an Amicus Brief on Cases of Torture, Abuse, and Injury.
Xenakis SN · J Am Acad Psychiatry Law · 2024Editorial
- Migalastat: First Global Approval.
Markham A · Drugs · 2016
- A Needling Controversy.
Berlin J · Tex Med · 2016
- Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness.
Barrow A, Cohen C, Serpico J, et al. · Perspect Sex Reprod Health · 2024
- Amicus or adversary: platelets in lung biology, acute injury, and inflammation.
Bozza FA, Shah AM, Weyrich AS, et al. · Am J Respir Cell Mol Biol · 2009Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LKN.
- Prosorba ColumnFresenius Hemocare, Inc. · PMA 2004
- Prosorba Protein a Immunoadsorption ColumnFresenius Hemocare, Inc. · PMA 2005
- Spectra Optia Apheresis SystemTerumobct, Inc. · 510(k) 2019
- Amicus Separator System/ Amicus Seperator SystemFenwal, Inc. · 510(k) 2014
- AMICUS Separator SystemFresenius Kabi AG · 510(k) 2019
- Spectra Optia Apheresis SystemTerumo Bct · 510(k) 2015
- Spectra Optia Apheresis SystemCaridianbct, Inc.. · 510(k) 2012
- Spectra Optia R Apheresis SystemCaridianbct, Inc.. · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.